Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Prevalentie en risicofactoren van juveniele myoclonus epilepsie
nov 2018 | Epilepsie